Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Research Brief: SOD1 Mutants Cause Early Vascular Changes
21 March 2008. A paper out March 16 in Nature Neuroscience from Berislav Zlokovic and colleagues at the University of Rochester in New York finds that mice expressing SOD1 mutations associated with inherited forms of amyotrophic lateral sclerosis (ALS) show vascular defects early in life, before motor neurons begin to degenerate. First author Zhihui Zhong and coworkers present evidence for a leaky blood-spinal cord barrier associated with microhemorrhages, neuroinflammation, reduced capillary density, and lowered blood flow. The researchers conclude that compromised circulation is an early event that could contribute to degeneration of motor neurons in these ALS models.

Previous work has shown breaches in the blood-brain barrier in symptomatic SOD1 mice with early or advanced disease (Garbuzova-Davis et al., 2007). In the new study, the effects show up presymptomatically, and get progressively worse with time. The appearance of vascular defects as early as two months of age precedes the onset of inflammation, and that then leads to further damage to the blood-brain barrier (BBB) as observed in people with ALS (Graves et al., 2004).

“Our study demonstrates that changes to the vasculature probably make an important contribution to the degeneration of large motor neurons in familial models of ALS,” the researchers conclude. The vascular changes, they showed, appeared to result from decreases in the expression of the tight junction proteins ZO-1, occludin and claudin-5 in endothelial cells that make up the BBB. “All of this evidence supports the idea that mutant-mediated damage to the vasculature contributes to initiating non-cell autonomous killing of motor neurons in inherited ALS,” they write.—Pat McCaffrey.

Reference:
Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O'Banion MK, Stojanovic K, Sagare A, Boillee S, Cleveland DW, Zlokovic BV. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci. 2008 Mar 16; [Epub ahead of print] Abstract

 
Comments on News and Primary Papers
  Comment by:  Ben Barres, ARF Advisor
Submitted 21 March 2008  |  Permalink Posted 21 March 2008

The mechanism by which SOD1 leads to motor neuron death in ALS is of great interest; much controversy has surrounded which are the relevant cell type(s) in which mutant SOD1 exerts its deleterious effects. This is a very interesting study demonstrating early blood-brain barrier (BBB) defects in the SOD1 mutant mouse model of ALS prior to frank neurodegeneration. SOD1 is expressed at very high levels in brain endothelial cells (our unpublished gene profiling data), up to twice the level of other brain cell types, and they may be preferentially vulnerable to injury in SOD1 mutants for this reason. The blood-brain barrier breakdown is also increasingly implicated in Alzheimer disease, though it remains unclear whether such changes occur early in AD or late in AD.

In the present paper the provocative observation is that these changes occur early. This is particularly interesting because of new (e.g., Stevens et al., 2007; Lobsiger et al., 2007) and old work (reviewed in   Read more


  Primary Papers: ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration.

Comment by:  Svitlana Garbuzova-Davis
Submitted 21 March 2008  |  Permalink Posted 21 March 2008

This is a thorough and important work, confirming and extending our original findings of dysfunction and structural damage, vascular leakage and edema, in the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) even in early-symptomatic G93A ALS mice (Garbuzova-Davis et al., 2007). The authors found BSCB damage in presymptomatic mice and in other ALS mouse models expressing different SOD mutations. Importantly, as we already know that inflammatory processes can alter the BBB, damage was noted in mice prior to the onset of inflammation. This also may have implications for other neurodegenerative diseases such as Alzheimer’s and Parkinson’s, where BBB damage has already been identified in patients. This finding, and our previous findings, may lead to revised pharmaceutical treatments for ALS, some of which assume a functional, intact BBB/BSCB. However, the article leaves open the questions of which disease mechanisms are affecting the BBB/BSCB and, our current focus, how the BBB/BSCB may be repaired.

View all comments by Svitlana Garbuzova-Davis

  Primary Papers: ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration.

Comment by:  George Perry (Disclosure)
Submitted 1 April 2008  |  Permalink Posted 3 April 2008
  I recommend this paper
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad